Heart Transplant Offer Acceptance Highest for White Women
By Elana Gotkine HealthDay Reporter
TUESDAY, March 26, 2024 -- The cumulative incidence of heart transplant offer acceptance is highest for White women, according to a study published online March 25 in the Journal of the American Medical Association.
Khadijah Breathett, M.D., from the Krannert Cardiovascular Research Center at Indiana University in Indianapolis, and colleagues conducted a cohort study to examine whether race or gender of a heart transplant candidate is associated with the probability of a donor heart being accepted by the transplant center team using the United Network for Organ Sharing datasets.
There were 14,890 candidates listed for heart transplant; of these, 30.9 and 69.1 percent were Black and White, respectively, and 73.6 and 26.4 percent were men and women, respectively. The researchers found that the highest cumulative incidence of acceptance was seen for White women, followed by Black women, White men, and Black men. For the first offer through the 16th offer, the odds of acceptance were less for Black than White candidates (odds ratio, 0.76 for first offer). For the first through the sixth offer, the odds of acceptance were higher for women than men (odds ratio, 1.53 for the first offer); the odds were lower for women for the 10th through the 31st offers.
"The cumulative incidence of donor heart offer acceptance by a transplant center team was consistently highest for White women followed by Black women, White men, and Black men," the authors write. "Further investigation is needed of the hospital-level decision-making process."
Several authors disclosed ties to the pharmaceutical and medical device industries.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Gains in Heart Failure Mortality Have Been Erased
FRIDAY, April 26, 2024 -- Declines in heart failure-related mortality from 1999 to 2012 were entirely reversed from 2012 to 2021, according to a research letter published online...
Reports of Injuries, Deaths Prompt FDA to Recall Heart Failure Devices
WEDNESDAY, April 17, 2024 -- The HeartMate II and HeartMate 3, manufactured by Thoratec Corp., a subsidiary of Abbott Laboratories, are now under a strict U.S. Food and Drug...
American College of Cardiology, April 6 to 8
The annual meeting of the American College of Cardiology was held from April 6 to 8 in Atlanta and attracted more than 12,000 participants, including clinicians, academicians...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.